These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17293112)

  • 1. Anti-formyl peptide antibodies.
    Tanaka F; Jones T; Kubitz D; Lerner RA
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1943-5. PubMed ID: 17293112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor.
    Higgins JD; Bridger GJ; Derian CK; Beblavy MJ; Hernandez PE; Gaul FE; Abrams MJ; Pike MC; Solomon HF
    J Med Chem; 1996 Mar; 39(5):1013-5. PubMed ID: 8676333
    [No Abstract]   [Full Text] [Related]  

  • 3. 2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis.
    Bruno O; Brullo C; Bondavalli F; Ranise A; Schenone S; Falzarano MS; Varani K; Spisani S
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3696-701. PubMed ID: 17475488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The main functions and structural modifications of tripeptide N-formyl-methionyl-leucyl-phenylalanine (fMLP) as a chemotactic factor.
    Yang KH; Fang H; Ye JS; Gong JZ; Wang JT; Xu WF
    Pharmazie; 2008 Nov; 63(11):779-83. PubMed ID: 19069235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple receptor states are required to describe both kinetic binding and activation of neutrophils via N-formyl peptide receptor ligands.
    Kinzer-Ursem TL; Sutton KL; Waller A; Omann GM; Linderman JJ
    Cell Signal; 2006 Oct; 18(10):1732-47. PubMed ID: 16530386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands.
    He HQ; Troksa EL; Caltabiano G; Pardo L; Ye RD
    J Biol Chem; 2014 Jan; 289(4):2295-306. PubMed ID: 24285541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formylpeptide receptor antagonists: structure and activity.
    Dalpiaz A; Pecoraro R; Vertuani G; Spisani S; Rizzuti O; Fabbri E; Scatturin A
    Boll Chim Farm; 1999 Mar; 138(3):44-8. PubMed ID: 10394703
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotaxis of Mercenaria mercenaria hemocytes to bacteria in vitro.
    Fawcett LB; Tripp MR
    J Invertebr Pathol; 1994 May; 63(3):275-84. PubMed ID: 8021525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of enzymes involved in the degradation of chemotactic N-formyl peptides.
    Nguyen KT; Pei D
    Biochemistry; 2005 Jun; 44(23):8514-22. PubMed ID: 15938642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tentacle type peptides as artificial lectins against sulfated Lewis X and A.
    Hyun S; Lee EH; Park J; Yu J
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4011-4. PubMed ID: 18565751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha,alpha-Cyclic aminoacids as useful scaffolds for the preparation of hNK(2) receptor antagonists.
    Sisto A; Altamura M; Cardinali F; D'Andrea P; Rossi C; Fattori D
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4841-4. PubMed ID: 17604625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoro-modified chemotactic peptides: fMLF analogues.
    Koksch B; Dahl C; Radics G; Vocks A; Arnold K; Arnhold J; Sieler J; Burger K
    J Pept Sci; 2004 Feb; 10(2):67-81. PubMed ID: 14994985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid alpha/beta-peptides: for-Met-Leu-Phe-OMe analogues containing geminally disubstituted beta2,2- and beta 3,3-amino acids at the central position.
    Mollica A; Paglialunga Paradisi M; Torino D; Spisani S; Lucente G
    Amino Acids; 2006 Jun; 30(4):453-9. PubMed ID: 16547648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial formyl peptides affect the innate cellular antimicrobial responses of larval Galleria mellonella (Insecta: Lepidoptera).
    Alavo TB; Dunphy GB
    Can J Microbiol; 2004 Apr; 50(4):279-89. PubMed ID: 15213752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of ligand binding modes at the human formyl peptide receptor 2.
    Chen T; Xiong M; Zong X; Ge Y; Zhang H; Wang M; Won Han G; Yi C; Ma L; Ye RD; Xu Y; Zhao Q; Wu B
    Nat Commun; 2020 Mar; 11(1):1208. PubMed ID: 32139677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-templated click chemistry for creation of novel DNA binding molecules.
    Imoto S; Hirohama T; Nagatsugi F
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5660-3. PubMed ID: 18793850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic peptides mimicking antigenic epitope of Helicobacter pylori urease.
    Białek M; Grabowski S; Kamiński Z; Kaca W
    Acta Biochim Pol; 2006; 53(1):83-6. PubMed ID: 16496040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes formulated with fMLP-modified cholesterol for enhancing drug concentration at inflammatory sites.
    Qin Y; Li ZW; Yang Y; Yu CM; Gu DD; Deng H; Zhang T; Wang X; Wang AP; Luo WZ
    J Drug Target; 2014 Feb; 22(2):165-74. PubMed ID: 24392736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of water in activation mechanism of human N-formyl peptide receptor 1 (FPR1) based on molecular dynamics simulations.
    Yuan S; Ghoshdastider U; Trzaskowski B; Latek D; Debinski A; Pulawski W; Wu R; Gerke V; Filipek S
    PLoS One; 2012; 7(11):e47114. PubMed ID: 23189124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further studies of tyrosine surrogates in opioid receptor peptide ligands.
    Dolle RE; Michaut M; Martinez-Teipel B; Belanger S; Graczyk TM; DeHaven RN
    Bioorg Med Chem Lett; 2007 May; 17(9):2656-60. PubMed ID: 17350835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.